Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Prof
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office COP300
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 146. Pesaturo K A, Johnson P N, Ramsey E Z. Pediatric pulmonary hypertension: A pharmacologic review. Journal of Pharmacy Practice. 2009; 22 : 166-178
147. Johnson P N, McGoodwin L, Banner, Jr W. Utilisation of Crotalidae polyvalent immune fab (ovine) for Viperidae envenomations in children. Emergency medicine journal : EMJ. 2008; 25 : 793-8
148. Johnson P N, Kuhn R J. Combination thrombolytic and anti-platelet therapies in an infant with incomplete kawasaki disease and coronary aneurysms. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2008; 13 : 242-50
149. Johnson P N, Gildon B. PrismaSol Monograph. 2008
150. Pesaturo K A, Ramsey E Z, Johnson P N, Taylor L M. Introduction to pediatric pharmacy practice: reflections of pediatrics practitioners. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2008; 65 : 1314-9
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 1. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Ellie Malehorn). Date: 2025.
2. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Avery Parman). Date: 2024.
3. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Dom Ropp). Date: 2023.
4. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Eugenie Chang). Date: 2023.
5. Society of Critical Care Medicine Presidential Citation. Date: 2022.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results